Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia
This group of patients with PH from Colombia were treated predominantly with monotherapy of calcium channel blockers and phosphodiesterase 5 inhibitors. However, current clinical practice guidelines recommend the use of combined therapy. The average persistence of the use of drugs for treatment for less than 6 months may be associated with difficulties in follow-up, adherence, effectiveness, tolerability, and access.
Authors
- Jorge Enrique Machado‐Alba (ORCID: https://orcid.org/0000-0002-8455-0936)
- Andrés Gaviria‐Mendoza (ORCID: https://orcid.org/0000-0003-2500-7658)
- R M SUAREZ
- Óscar David Saidiza Peñuela
- Luis Fernando Valladales‐Restrepo (ORCID: https://orcid.org/0000-0002-4245-0101)
- Manuel Pacheco (ORCID: https://orcid.org/0000-0001-6783-1608)
- Manuel Enrique Machado‐Duque (ORCID: https://orcid.org/0000-0001-8458-0986)
- Juan‐Sebastian Franco (ORCID: https://orcid.org/0000-0001-7776-9270)
- María del Rosario Forero
Institutions
- Technological University of Pereira (CO)
- Institución Universitaria Visión de las Américas (CO)
Publication Details
- Journal
- The Clinical Respiratory Journal
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/crj.70063
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Bayer